fromwww.theguardian.com3 weeks ago23andMe's founder wins bid to regain control of bankrupt DNA testing firmAnne Wojcicki's non-profit bid of $305 million has surpassed Regeneron Pharmaceuticals' offer of $256 million for the troubled genetic testing firm 23andMe.Marketing tech